Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO 2019 Congress

Radiopharmaceuticals to treat lethal prostate cancer

Presentation by expert

Date

28 Sep 2019

Session

Radiopharmaceuticals to treat lethal prostate cancer

Topics

Radiation Oncology

Tumour Site

Prostate Cancer

Presenters

Chris Parker

Authors

C. Parker

Author affiliations

  • Urology, The Institute of Cancer Research/Royal Marsden NHS Foundation Trust, SM2 5PT - Sutton/GB

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Discussion led by Chair

Presenter: Aristotelis Bamias

Session: Radiopharmaceuticals to treat lethal prostate cancer

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.